Literature DB >> 26909811

[Treatment of vitiligo].

M Meurer1, M Schild2.   

Abstract

The range of treatment options for vitiligo has significantly expanded in the last 10 years and we can offer our patients more effective treatment strategies supported by European guidelines and consensus findings. Topical and UV therapy are-often in combination-the main components of vitiligo treatment. The main outcome parameters include extent and maintenance of gained repigmentation, cessation of spreading, avoidance of side effects and the influence of the treatment on the quality of life. The efficacy of the currently available treatments is often limited. New options include antioxidative or melanocyte-stimulating adjuvant therapies in combination with UV or laser light as well as a topical maintenance treatment to reduce the risk of recurrences. In many cases, psychological support is indicated.

Entities:  

Keywords:  Glucocorticoids; Laser therapy; Progression; Quality of life; Topical treatment

Mesh:

Substances:

Year:  2016        PMID: 26909811     DOI: 10.1007/s00105-016-3768-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  84 in total

1.  Repigmentation of vitiligo with topical tacrolimus.

Authors:  D A Smith; S J Tofte; J M Hanifin
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

2.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force.

Authors:  Alain Taïeb; Mauro Picardo
Journal:  Pigment Cell Res       Date:  2007-02

3.  Etanercept in the treatment of vitiligo.

Authors:  Dimitris Rigopoulos; Stamatis Gregoriou; George Larios; Evi Moustou; Elena Belayeva-Karatza; Dimitris Kalogeromitros
Journal:  Dermatology       Date:  2007       Impact factor: 5.366

4.  Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL).

Authors:  Evelyn Lilly; Phoebe D Lu; Judy H Borovicka; David Victorson; Mary J Kwasny; Dennis P West; Roopal V Kundu
Journal:  J Am Acad Dermatol       Date:  2012-02-25       Impact factor: 11.527

5.  Guidelines for the management of vitiligo: the European Dermatology Forum consensus.

Authors:  A Taieb; A Alomar; M Böhm; M L Dell'anna; A De Pase; V Eleftheriadou; K Ezzedine; Y Gauthier; D J Gawkrodger; T Jouary; G Leone; S Moretti; L Nieuweboer-Krobotova; M J Olsson; D Parsad; T Passeron; A Tanew; W van der Veen; N van Geel; M Whitton; A Wolkerstorfer; M Picardo
Journal:  Br J Dermatol       Date:  2012-11-02       Impact factor: 9.302

6.  Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.

Authors:  M S Kumaran; I Kaur; B Kumar
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-03       Impact factor: 6.166

Review 7.  Computer simulation of native epidermal enzyme structures in the presence and absence of hydrogen peroxide (H2O2): potential and pitfalls.

Authors:  Nicholas C J Gibbons; John M Wood; Hartmut Rokos; Karin U Schallreuter
Journal:  J Invest Dermatol       Date:  2006-12       Impact factor: 8.551

8.  The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.

Authors:  Pearl E Grimes; Iltefat Hamzavi; Mark Lebwohl; Jean Paul Ortonne; Henry W Lim
Journal:  JAMA Dermatol       Date:  2013-01       Impact factor: 10.282

9.  Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study.

Authors:  Michael Meurer; Regina Fölster-Holst; Gottfried Wozel; Gottfried Weidinger; Michael Jünger; Matthias Bräutigam
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

10.  Vitiligo and the melanocyte reservoir.

Authors:  Rafael Falabella
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more
  2 in total

Review 1.  [Systemic treatment of vitiligo : Balance and current developments].

Authors:  M Meurer; P Ceric-Dehdari
Journal:  Hautarzt       Date:  2017-11       Impact factor: 0.751

2.  Epidermal skin grafting in vitiligo: a pilot study.

Authors:  Agata Janowska; Valentina Dini; Salvatore Panduri; Michela Macchia; Teresa Oranges; Marco Romanelli
Journal:  Int Wound J       Date:  2016-09       Impact factor: 3.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.